This article was originally published on this site
The Green Organic Dutchman Holdings Ltd. (TGOD:CA) (TGODF) ()announced today that it has selected Shopify Inc. (SHOP) (SHOP:CA) ()to build an innovative ecommerce platform for the delivery of medical and future adult-use organic cannabis world-wide.
The Green Organic Dutchman Holdings Ltd. (TGOD) is a research & development company licensed under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) to cultivate medical cannabis in Canada. TGOD is developing large scale production, global distribution channels and a premium brand to become the leading supplier of organic cannabis worldwide. TGOD is committed to building a powerful, scalable ecommerce solution, and is proud to implement Shopify’s innovative ecommerce platform.
Shopify is the leading cloud-based multichannel ecommerce platform. The company was involved in the partnership between TGOD and Epican Medicinals in Jamaica where they supplied the retail point-of-sale system for Epican’s retail outlets. Additionally, Shopify is developing the pre-registration system for medical patients throughout Jamaica. TGOD will leverage this expertise as it plans for the sale of organic cannabis in domestic and international markets.
“We are pleased to announce this agreement with ecommerce giant Shopify,” said Csaba Reider, President of TGOD. “We see tremendous value in this relationship and Shopify will play an instrumental role in our ability to rapidly scale and provide our premium organic cannabis to global markets.”
“We look forward to working with The Green Organic Dutchman on the development of their online store for medical and adult-use cannabis,” said Loren Padelford, VP & GM at Shopify. “Our platform will allow TGOD to rapidly scale and capitalize on emerging cannabis opportunities in a safe, secure, and reliable way.”
On Behalf of the Board of Directors,
The Green Organic Dutchman Holdings Ltd.
ABOUT THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD.
The Green Organic Dutchman Holdings Ltd. is a research & development company licensed under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) to cultivate medical cannabis. The Company carries out its principal activities producing cannabis from its facilities in Ancaster, Ont., pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations.
The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a funded capacity of 170,000 kg and is building 1,382,000 sq. ft. of cultivation facilities in Ontario, Quebec and Jamaica.
The Company has developed a strategic partnership with Aurora Cannabis Inc. (TSX:ACB) whereby Aurora has invested approximately C$78.1 million for an approximate 17.5% stake in TGOD. In addition, the Company has raised approximately C$350 million dollars and has over 20,000 shareholders.
TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.
In the interest of full disclosure, we call the reader’s attention to the fact that Equities.com, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by Equities.com to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle. Equities has been compensated with cash, common shares and/or warrants for market awareness services provided.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer